# A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

> **NCT00038636** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 36 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT00038636
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 36 (—)
- **Last updated:** 2006-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038636, "A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00038636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*